OGN - Organon & Co. (OGN) CEO Kevin Ali Presents at 42nd Annual Cowen Health Care Conference (Transcript)

Organon & Co. (OGN) 42nd Annual Cowen Health Care Conference March 09, 2022 09:10 AM ET Company Participants Kevin Ali - Chief Executive Officer Matthew Walsh - Chief Financial Officer Sandra Mulligan - Head, R&D Conference Call Participants Steve Scala - Cowen Michael Nedelcovych - Cowen Presentation Steve Scala Good morning, and welcome to the Organon session of Cowen's 42nd Annual Healthcare Conference. We're very pleased to have with us the top management of Organon, one of the most unique and exciting and emerging companies in the biopharma space. So, we're very pleased to have you with us at our conference. Representing the company is Kevin Ali, who is the Chief Executive Officer; Matthew Walsh, CFO; Sandra Mulligan, who is the Head of R&D and Jen Halchak, who is the Head of Investor Relations. Question-and-Answer Session Q - Steve Scala So, with that, I'd like just to dive right into

For further details see:

Organon & Co. (OGN) CEO Kevin Ali Presents at 42nd Annual Cowen Health Care Conference (Transcript)